Literature DB >> 12010194

Role of angiotensin II receptors in the regulation of vasomotor neurons in the ventrolateral medulla.

R A L Dampney1, M A P Fontes, Y Hirooka, J Horiuchi, P D Potts, T Tagawa.   

Abstract

1. There is a high density of angiotensin type 1 (AT1) receptors in various brain regions involved in cardiovascular regulation. The present review will focus on the role of AT1 receptors in regulating the activity of sympathetic premotor neurons in the rostral part of the ventrolateral medulla (VLM), which are known to play a pivotal role in the tonic and phasic regulation of sympathetic vasomotor activity and arterial pressure. 2. Microinjection of angiotensin (Ang) II into the rostral VLM (RVLM) results in an increase in arterial pressure and sympathetic vasomotor activity. These effects are blocked by prior application of losartan, a selective AT1 receptor antagonist, indicating that they are mediated by AT1 receptors. However, microinjection of AngII into the RVLM has no detectable effect on respiratory activity, indicating that AT1 receptors are selectively or even exclusively associated with vasomotor neurons in this region. 3. Under normal conditions in anaesthetized animals, AT1 receptors do not appear to contribute significantly to the generation of resting tonic activity in RVLM sympathoexcitatory neurons. However, recent studies suggest that they contribute significantly to the tonic activity of these neurons under certain conditions, such as salt deprivation or heart failure, or in spontaneously hypertensive or genetically modified rats in which the endogenous levels of AngII are increased or in which AT1 receptors are upregulated. 4. Recent evidence also indicates that AT1 receptors play an important role in mediating phasic excitatory inputs to RVLM sympathoexcitatory neurons in response to activation of some neurons within the hypothalamic paraventricular nucleus. The physiological conditions that lead to activation of these AT1 receptor-mediated inputs are unknown. Further studies are also required to determine the cellular mechanisms of action of AngII in the RVLM and its interactions with other neurotransmitters in that region.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010194     DOI: 10.1046/j.1440-1681.2002.03658.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  23 in total

1.  Chronic infusion of angiotensin receptor antagonists in the hypothalamic paraventricular nucleus prevents hypertension in a rat model of sleep apnea.

Authors:  Ana Quenia Gomes da Silva; Marco Antônio Peliky Fontes; Nancy Lapp Kanagy
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

Review 2.  Neurohormonal regulation of the sympathetic nervous system: new insights into central mechanisms of action.

Authors:  Scott H Carlson; J Michael Wyss
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369

Review 3.  Angiotensin II, Oxidative Stress, and Sympathetic Nervous System Hyperactivity in Heart Failure.

Authors:  Satoshi Koba
Journal:  Yonago Acta Med       Date:  2018-06-18       Impact factor: 1.641

4.  Angiotensin-(1-12) in the rostral ventrolateral medullary pressor area of the rat elicits sympathoexcitatory responses.

Authors:  Hideki Arakawa; Kazumi Kawabe; Hreday N Sapru
Journal:  Exp Physiol       Date:  2012-06-15       Impact factor: 2.969

5.  MicroRNA network changes in the brain stem underlie the development of hypertension.

Authors:  Danielle DeCicco; Haisun Zhu; Anthony Brureau; James S Schwaber; Rajanikanth Vadigepalli
Journal:  Physiol Genomics       Date:  2015-06-30       Impact factor: 3.107

6.  Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen.

Authors:  Amy C Arnold; Atsushi Sakima; Detlev Ganten; Carlos M Ferrario; Debra I Diz
Journal:  Hypertension       Date:  2008-03-17       Impact factor: 10.190

7.  Enhanced angiotensin-mediated excitation of renal sympathetic nerve activity within the paraventricular nucleus of anesthetized rats with heart failure.

Authors:  Hong Zheng; Yi-Fan Li; Wei Wang; Kaushik P Patel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-26       Impact factor: 3.619

Review 8.  Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives.

Authors:  Shereeni J Veerasingham; Mohan K Raizada
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  Glutamatergic receptor activation in the rostral ventrolateral medulla mediates the sympathoexcitatory response to hyperinsulinemia.

Authors:  Megan E Bardgett; John J McCarthy; Sean D Stocker
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

10.  Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappaB.

Authors:  Yu-Ming Kang; Ying Ma; Carrie Elks; Jin-Ping Zheng; Zhi-Ming Yang; Joseph Francis
Journal:  Cardiovasc Res       Date:  2008-05-10       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.